- Report
- February 2025
- 200 Pages
Global
From €4096EUR$4,490USD£3,501GBP
- Report
- August 2022
- 120 Pages
Global
From €4105EUR$4,500USD£3,509GBP
- Report
- April 2025
- 50 Pages
Global
From €2417EUR$2,650USD£2,066GBP
Trandolapril is a cardiovascular drug used to treat hypertension, congestive heart failure, and to reduce the risk of death after a heart attack. It is an angiotensin-converting enzyme (ACE) inhibitor, which works by blocking the production of a hormone that causes blood vessels to narrow. Trandolapril is available in both oral and intravenous forms, and is often used in combination with other drugs to treat hypertension. It is also used to reduce the risk of stroke in people with high blood pressure.
Trandolapril is generally well-tolerated, with few side effects. Common side effects include headache, dizziness, and fatigue. More serious side effects include low blood pressure, kidney failure, and an increased risk of angioedema.
Trandolapril is marketed by several pharmaceutical companies, including Merck, Novartis, and Pfizer. Other companies that produce trandolapril include Mylan, Sandoz, and Teva Pharmaceuticals. Show Less Read more